Danish researchers have developed a technology that identifies and measures the concentration of pharmaceuticals in the blood in under 10 minutes. The faster turn-around time can mean the difference between life and death
DNA methylation patterns in blood could identify people at high risk of prostate or breast cancer up to eight years before diagnosis, Oxford Population Health researchers report.
Monitoring blood test trends alongside unexplained weight loss can provide further clues about a patient’s risk of developing cancer, according to a new study.
Using a specialized “broth”, researchers have developed a way to condense the days-long diagnosis timeline for sepsis to just hours, facilitating faster diagnosis and clinical decision-making.
Blood tests yield vital information about Alzheimer’s disease. However, new research suggests that relevant biomarkers may differ significantly across patient populations.
More biomarkers for better insights on Alzheimer's disease: a new study explores how a panel of seven proteins could help predict disease progression and inform more accurate treatment choices.
A blood test for ctDNA may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to new research.
Blood tests show promise for detecting and monitoring cancer. A new method makes it possible to analyse samples containing as little as 5% cancer DNA, compared with the 15–20% required today.
New research reveals that extracellular vesicles derived from menstrual blood stromal cells can improve cartilage repair, suggesting an innovative cell-free therapy for osteoarthritis.
Researchers report on decisive steps towards an early diagnosis of Parkinson’s disease: a newly discovered biomarker in the blood could open a window of opportunity for future treatment.
The Blood Transfusion service at Aneurin Bevan University Health Board (ABUHB) has implemented Clinisys WinPath LIMS, marking the first deployment of this system in Wales.
Analytical and measurement technology copany Horiba has obtained CE IVDR certification for its new Yumizen H500 CRP benchtop hematology analyzer, designed for small laboratories.
Non-specific symptoms such as fatigue, pain or weight loss can be caused by cancer, another serious condition or something completely harmless. A blood test can help provide relevant information.
Siemens Healthineers, with funding from the Gates Foundation, plans to develop artificial intelligence (AI) to enable earlier prediction of pre-eclampsia and anemia in low-resource settings.
An international study shows that Alzheimer’s disease biomarkers can be accurately detected using simple finger-prick blood samples that can be collected at home and mailed to a laboratory.
A simple blood test that can very accurately predict the chance of survival with good recovery could be of great significance for patients in intensive care after a cardiac arrest.
Researchers have created a system that uses generative AI to study the shape and structure of blood cells, and spot unusual or rare cells that may indicate disease such as leukaemia.
Newly discovered blood biomarkers may offer new options to track Duchenne muscular dystrophy (DMD) in a less invasive way than physical tests or biopsies. This could support more tailored treatments.
Chronic fatigue (ME/CFS) affects millions worldwide, but is poorly understood and has long lacked reliable diagnostic tools. Now, a new blood test claims to diagnose the condition with 96% accuracy.
